AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol (December 30, 2005). doi:10.1152/ajpheart.01142.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/H2146    most recent
01142.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jesmin, S.
Right arrow Articles by Miyauchi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jesmin, S.
Right arrow Articles by Miyauchi, T.
Submitted on October 28, 2005
Accepted on December 16, 2005

The Subdepressor Dose of Benidipine Ameliorates Diabetic Cardiac Remodeling Accompanied by the Normalization of the Upregulated Endothelin System in Rats

Subrina Jesmin1, Yuichi Hattori2, Seiji Maeda1, Sohel Zaedi1, Ichiro Sakuma3, and Takashi Miyauchi1*

1 Department of Cardiovascular Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
2 Department of Pharmacology, School of Medicine, University of Toyama, Toyama, Japan
3 Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan

* To whom correspondence should be addressed. E-mail: t-miyauc{at}md.tsukuba.ac.jp.

We investigated if benidipine, a long-acting calcium channel blocker (CCB), can normalize cardiac expression profiles of the endothelin (ET)-1 system in insulin-resistant diabetes. Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of human type 2 diabetes, were treated for 12 weeks with vehicle or benidipine (3 mg/kg/day). OLETF rats exhibited a significant increase in ET-1 in plasma and left ventricular (LV)tissues compared with non-diabetic controls. Expression of preproET-1, ET converting enzyme, ETA and ETB receptors in LV tissues was also significantly higher in OLETF rats. The two mitogen-activated protein kinases (MAPKs), c-Jun N-terminal kinase and p38MAPK, both of which are activated by ET-1, were more abundantly expressed in OLETF rat LV tissues. All these alterations were reversed to non-diabetic levels when OLETF rats were treated with at the subdepressor dose of benidipine. Furthermore, benidipine therapy resulted in hindering cardiomyocyte hypertrophy and cardiac perivascular fibrosis in OLETF rats. The beneficial actions of benidipine at the subdepressor dose on cardiac remodeling in insulin-resistant diabetes may involve normalization of the upregulated ET-1 system.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
T. Matsumoto, K. Ishida, N. Nakayama, T. Kobayashi, and K. Kamata
Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat
Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1388 - H1397.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.